192 related articles for article (PubMed ID: 37082914)
21. Blastic plasmacytoid dendritic cell neoplasm: A clinicopathological diagnostic dilemma report of three cases with review of literature.
Purkait S; Gupta S; Bakhshi S; Mallick S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S471-S474. PubMed ID: 36511007
[TBL] [Abstract][Full Text] [Related]
22. Dendritic Cell Leukemia: a Review.
Tsagarakis NJ; Paterakis G
Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
[TBL] [Abstract][Full Text] [Related]
23. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha).
Piña-Oviedo S; Herrera-Medina H; Coronado H; Del Valle L; Ortiz-Hidalgo C
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
[TBL] [Abstract][Full Text] [Related]
25. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.
Nasiri A; Lami A; Alhumaidi A; Madkhali A; Althaqib A; Aljarwan N; Alkharras R
Cureus; 2023 Apr; 15(4):e37016. PubMed ID: 37026111
[TBL] [Abstract][Full Text] [Related]
26. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
[TBL] [Abstract][Full Text] [Related]
27. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
28. Blastic plasmacytoid dendritic cell neoplasm: an early presentation.
Silveira SO; Fernandes CMA; Pinto ÉB; Einecke YS; Palheta CDSA; Brito CVB; Dias Júnior LB; Carneiro FRO
Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865410
[TBL] [Abstract][Full Text] [Related]
29. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract][Full Text] [Related]
30. TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
Alayed K; Patel KP; Konoplev S; Singh RR; Routbort MJ; Reddy N; Pemmaraju N; Zhang L; Shaikh AA; Aladily TN; Jain N; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2013 Dec; 88(12):1055-61. PubMed ID: 23940084
[TBL] [Abstract][Full Text] [Related]
31. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous lesion.
Awasthi NP; Qayoom S; Dabadghao S
J Cancer Res Ther; 2017; 13(6):1056-1058. PubMed ID: 29237977
[TBL] [Abstract][Full Text] [Related]
32. [Clinical Features of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Wu LZ; Yu Q; Jiang Y; Peng HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):307-313. PubMed ID: 32027294
[TBL] [Abstract][Full Text] [Related]
33. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study of 7 cases].
Xiong J; Chen H; Zhang M; Zheng Y; Qiao J; Sheng N; Xu X; Sun J
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):599-602. PubMed ID: 24762690
[TBL] [Abstract][Full Text] [Related]
34. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review.
Ding Y; Yang J; Lindsey K
Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895
[TBL] [Abstract][Full Text] [Related]
35. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D
J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.
Cota C; Vale E; Viana I; Requena L; Ferrara G; Anemona L; Metze D; Fink-Puches R; Wiesner T; Cerroni L
Am J Surg Pathol; 2010 Jan; 34(1):75-87. PubMed ID: 19956058
[TBL] [Abstract][Full Text] [Related]
37. Targeting CD123 in BPDCN: an emerging field.
DiPippo AJ; Wilson NR; Pemmaraju N
Expert Rev Hematol; 2021 Nov; 14(11):993-1004. PubMed ID: 34607517
[TBL] [Abstract][Full Text] [Related]
38. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
39. Unusual morphologic presentations of blastic plasmacytoid dendritic cell neoplasm: report of two cases misdiagnosed as melanoma and leprosy.
León-Martínez G; Meillón-García L; Morales-Polanco M; Soler-Montecinos L; Ortiz-Hidalgo C
Int J Surg Pathol; 2014 Feb; 22(1):76-82. PubMed ID: 23515558
[TBL] [Abstract][Full Text] [Related]
40. CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm.
Bôle-Richard E; Fredon M; Biichlé S; Anna F; Certoux JM; Renosi F; Tsé F; Molimard C; Valmary-Degano S; Jenvrin A; Warda W; Pallandre JR; Bonnefoy F; Poussard M; Deschamps M; Petrella T; Roumier C; Macintyre E; Féger F; Brissot E; Mohty M; HoWangYin KY; Langlade-Demoyen P; Loustau M; Caumartin J; Godet Y; Binda D; Pagadoy M; Deconinck E; Daguindau E; Saas P; Ferrand C; Angelot-Delettre F; Adotévi O; Garnache-Ottou F
Leukemia; 2020 Dec; 34(12):3228-3241. PubMed ID: 32111969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
